Seres Therapeutics Inc (MCRB) Directors and Executive Officers

Officers & Directors

Dennis A. Ausiello
Director

Paul R. Biondi
Director

Kurt C. Graves
Director

Richard N. Kender
Director

Stephen Berenson
Chairman of the Board

Willard H. Dere
Director

Eric D. Shaff
President, Chief Executive Officer, and Director

Claire M. Fraser
Director

David Arkowitz
Executive Vice President, Chief Financial Officer, and Head of Business Development ,

Seres Therapeutics Inc currently has 66 employees.

News about Seres Therapeutics Inc Key Personnel

Seres Therapeutics Finalizes VOWST Sale to Nestlé Health Science Amid Financial Losses, Focuses on Advancing Live Biotherapeutics Development,

In a landmark strategic move, Seres Therapeutics, Inc. (Nasdaq: MCRB), headquartered in Cambridge, Massachusetts, has successfully completed the sale of its VOWST business to Societé des Produits Nestlé S.A. a subsidiary of Nestlé Health Science. This decision comes as part of Seres’ broader strategy to align its resources on the development of its core offerings, particularly its promising live biotherapeutics targeting medically vulnerable populations at risk for life-threatening bacterial infections.On September 26, 2024, Seres Therapeutics reported that its stockholders overwhelmingly approved the sale of VOWST, following an announcement earlier in the month that indicated the transaction was forthc...